Volume 14 Issue 1
Jan.  2023
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2023  >  14(1): 93-99
Zheng Shanshan, Zheng Zhe, Song Yunhu, et al. Application of extracorporeal membrane oxygenation in early allograft dysfunction after heart transplantation[J]. ORGAN TRANSPLANTATION, 2023, 14(1): 93-99. doi: 10.3969/j.issn.1674-7445.2023.01.012
Citation: Zheng Shanshan, Zheng Zhe, Song Yunhu, et al. Application of extracorporeal membrane oxygenation in early allograft dysfunction after heart transplantation[J]. ORGAN TRANSPLANTATION, 2023, 14(1): 93-99. doi: 10.3969/j.issn.1674-7445.2023.01.012
shu

Application of extracorporeal membrane oxygenation in early allograft dysfunction after heart transplantation

doi: 10.3969/j.issn.1674-7445.2023.01.012

  • Department of Cardiac Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China

More Information
  • Corresponding author: Liu Sheng, Email: liusheng@fuwai.com
  • Received Date: 2022-08-29
    Available Online: 2023-01-17
  • Publish Date: 2023-01-15
    Abstract
  •   Objective  To evaluate the effect of extracorporeal membrane oxygenation (ECMO) on early allograft dysfunction (EAD) after heart transplantation.  Methods  Clinical data of 614 heart transplant recipients were retrospectively analyzed. All recipients were divided into the ECMO group (n=43) and non-ECMO group (n=571) according to postoperative application of ECMO. In the ECMO group, the conditions of recipients undergoing ECMO after heart transplantation were summarized. Perioperative status and long-term prognosis of recipients were compared between two groups.  Results  Among 43 recipients undergoing ECMO, 17 cases underwent thoracotomy due to bleeding, 10 cases of infection, 4 cases of venous thrombosis of the lower limbs, and 1 case of stroke, respectively. Twenty-six recipients were recovered and discharged after successful weaning from ECMO, six died during ECMO support, six died after weaning from ECMO, five received retransplantation due to unsuccessful weaning from ECMO, and only one survived after retransplantation. Compared with the non-ECMO group, intraoperative cardiopulmonary bypass duration was significantly longer, the proportion of recipients requiring postoperative intra-aortic balloon pump (IABP), dialysis due to renal insufficiency, reoperation for hemostasis, infection, mechanical ventilation time≥96 h and tracheotomy was significantly higher, and the length of postoperative intensive care unit (ICU) stay was significantly longer in the ECMO group (all P < 0.05). The survival rate after discharge and 90-d survival rate in the ECMO group were 63% and 96%, significantly lower than 97% and 100% in the non-ECMO group (both P < 0.05). Survival analysis showed that the long-term survival rate in the ECMO group was significantly lower than that in the non-ECMO group (P < 0.05). After excluding the recipients who died within 90 d after heart transplantation, no significant difference was observed in the long-term survival rate (P > 0.05).  Conclusions  ECMO is an effective treatment of EAD after heart transplantation. The short-term survival rate of recipients using ECMO after heart transplantation is lower than that of those who do not use ECMO, and there is no significant difference in long-term survival of recipients surviving 90 d after heart transplantation.

     

    • FullText(HTML)
  • loading
    • References(30)
  • [1]
    KHUSH KK, HSICH E, POTENA L, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-eighth adult heart transplantation report - 2021; focus on recipient characteristics[J]. J Heart Lung Transplant, 2021, 40(10): 1035-1049. DOI: 10.1016/j.healun.2021.07.015.
    [2]
    SINGH SSA, DALZELL JR, BERRY C, et al. Primary graft dysfunction after heart transplantation: a thorn amongst the roses[J]. Heart Fail Rev, 2019, 24(5): 805-820. DOI: 10.1007/s10741-019-09794-1.
    [3]
    SUBRAMANI S, ALDRICH A, DWARAKANATH S, et al. Early graft dysfunction following heart transplant: prevention and management[J]. Semin Cardiothorac Vasc Anesth, 2020, 24(1): 24-33. DOI: 10.1177/1089253219867694.
    [4]
    KOBASHIGAWA J, ZUCKERMANN A, MACDONALD P, et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation[J]. J Heart Lung Transplant, 2014, 33(4): 327-340. DOI: 10.1016/j.healun.2014.02.027.
    [5]
    NICOARA A, RUFFIN D, COOTER M, et al. Primary graft dysfunction after heart transplantation: incidence, trends, and associated risk factors[J]. Am J Transplant, 2018, 18(6): 1461-1470. DOI: 10.1111/ajt.14588.
    [6]
    PRIETO D, CORREIA PM, BATISTA M, et al. Primary graft failure after cardiac transplantation: prevalence, prognosis and risk factors[J]. Interact Cardiovasc Thorac Surg, 2018, 27(5): 765-772. DOI: 10.1093/icvts/ivy151.
    [7]
    TRUBY LK, DEROO S, SPELLMAN J, et al. Management of primary graft failure after heart transplantation: preoperative risks, perioperative events, and postoperative decisions[J]. Clin Transplant, 2019, 33(6): e13557. DOI: 10.1111/ctr.13557.
    [8]
    AL-ADHAMI A, AVTAAR SINGH SS, DE SD, et al. Primary graft dysfunction after heart transplantation - unravelling the enigma[J]. Curr Probl Cardiol, 2022, 47(8): 100941. DOI: 10.1016/j.cpcardiol.2021.100941.
    [9]
    BENCK L, KRANSDORF EP, EMERSON DA, et al. Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant[J]. J Heart Lung Transplant, 2021, 40(9): 970-980. DOI: 10.1016/j.healun.2021.06.002.
    [10]
    BUCHAN TA, MOAYEDI Y, TRUBY LK, et al. Incidence and impact of primary graft dysfunction in adult heart transplant recipients: a systematic review and meta-analysis[J]. J Heart Lung Transplant, 2021, 40(7): 642-651. DOI: 10.1016/j.healun.2021.03.015.
    [11]
    WILKEY BJ, ABRAMS BA. Mitigation of primary graft dysfunction in lung transplantation: current understanding and hopes for the future[J]. Semin Cardiothorac Vasc Anesth, 2020, 24(1): 54-66. DOI: 10.1177/1089253219881980.
    [12]
    KRISHNAMOORTHY B, MEHTA V, CRITCHLEY W, et al. Financial implications of using extracorporeal membrane oxygenation following heart transplantation[J]. Interact Cardiovasc Thorac Surg, 2021, 32(4): 625-631. DOI: 10.1093/icvts/ivaa307.
    [13]
    KAWABORI M, MASTROIANNI MA, ZHAN Y, et al. A case series: the outcomes, support duration, and graft function recovery after VA-ECMO use in primary graft dysfunction after heart transplantation[J]. J Artif Organs, 2020, 23(2): 140-146. DOI: 10.1007/s10047-019-01146-y.
    [14]
    LOFORTE A, FIORENTINO M, MURANA G, et al. Mechanically supported early graft failure after heart transplantation[J]. Transplant Proc, 2021, 53(1): 311-317. DOI: 10.1016/j.transproceed.2020.07.005.
    [15]
    POZZI M, BOTTIN C, ARMOIRY X, et al. Extracorporeal life support for primary graft dysfunction after heart transplantation[J]. Interact Cardiovasc Thorac Surg, 2018, 27(5): 778-784. DOI: 10.1093/icvts/ivy157.
    [16]
    SABATINO M, VITALE G, MANFREDINI V, et al. Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: epidemiology, risk factors, and outcomes[J]. J Heart Lung Transplant, 2017, 36(11): 1217-1225. DOI: 10.1016/j.healun.2017.02.014.
    [17]
    AVTAAR SINGH SS, BANNER NR, RUSHTON S, et al. ISHLT primary graft dysfunction incidence, risk factors, and outcome: a UK national study[J]. Transplantation, 2019, 103(2): 336-343. DOI: 10.1097/TP.0000000000002220.
    [18]
    SETTEPANI F, PEDRAZZINI GL, OLIVIERI GM, et al. Long-term effects of primary graft dysfunction after heart transplantation[J]. J Card Surg, 2022, 37(5): 1290-1298. DOI: 10.1111/jocs.16364.
    [19]
    SHUDO Y, ALASSAR A, WANG H, et al. Post-transplant extracorporeal membrane oxygenation for severe primary graft dysfunction to support the use of marginal donor hearts[J]. Transpl Int, 2022, 35: 10176. DOI: 10.3389/ti.2022.10176.
    [20]
    BARGE-CABALLERO G, CASTEL-LAVILLA MA, ALMENAR-BONET L, et al. Venoarterial extracorporeal membrane oxygenation with or without simultaneous intra-aortic balloon pump support as a direct bridge to heart transplantation: results from a nationwide Spanish registry[J]. Interact Cardiovasc Thorac Surg, 2019, 29(5): 670-677. DOI: 10.1093/icvts/ivz155.
    [21]
    CLERKIN KJ, MANCINI DM, STEHLIK J, et al. Continuous-flow mechanical circulatory support is not associated with early graft failure: an analysis of the International Society for Heart and Lung Transplantation registry[J]. Clin Transplant, 2019, 33(12): e13752. DOI: 10.1111/ctr.13752.
    [22]
    HULMAN M, ARTEMIOU P, ONDRUSEK M, et al. Short-term mechanical circulatory support for severe primary graft dysfunction following orthotopic heart transplant[J]. Interact Cardiovasc Thorac Surg, 2018, 27(2): 229-233. DOI: 10.1093/icvts/ivy050.
    [23]
    TAKEDA K, LI B, GARAN AR, et al. Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant[J]. J Heart Lung Transplant, 2017, 36(6): 650-656. DOI: 10.1016/j.healun.2016.12.006.
    [24]
    RIZVI SA, LUC JGY, CHOI JH, et al. Outcomes and survival following heart retransplantation for cardiac allograft failure: a systematic review and meta-analysis[J]. Ann Cardiothorac Surg, 2018, 7(1): 12-18. DOI: 10.21037/acs.2018.01.09.
    [25]
    DEROO SC, TAKAYAMA H, NEMETH S, et al. Extracorporeal membrane oxygenation for primary graft dysfunction after heart transplant[J]. J Thorac Cardiovasc Surg, 2019, 158(6): 1576-1584. DOI: 10.1016/j.jtcvs.2019.02.065.
    [26]
    GUO A, KOTKAR K, SCHILLING J, et al. Improvements in extracorporeal membrane oxygenation for primary graft failure after heart transplant[J]. Ann Thorac Surg, 2022, DOI: 10.1016/j.athoracsur.2022.03.065[Epub ahead of print].
    [27]
    HOU JY, LI X, YANG SG, et al. Veno-arterial extracorporeal membrane oxygenation for patients undergoing heart transplantation: a 7-year experience[J]. Front Med (Lausanne), 2021, 8: 774644. DOI: 10.3389/fmed.2021.774644.
    [28]
    CONNOLLY S, GRANGER E, HAYWARD C, et al. Long-term outcome in severe left ventricular primary graft dysfunction post cardiac transplantation supported by early use of extracorporeal membrane oxygenation[J]. Transplantation, 2020, 104(10): 2189-2195. DOI: 10.1097/TP.0000000000003094.
    [29]
    ZHAO C, HAO X, XUE C, et al. Impact of extracorporeal membrane oxygenation on right ventricular function after heart transplantation[J]. Front Cardiovasc Med, 2022, 9: 938442. DOI: 10.3389/fcvm.2022.938442.
    [30]
    JANG J, KOO SM, KIM KU, et al. Clinical experiences of high-risk pulmonary thromboembolism receiving extracorporeal membrane oxygenation in single institution[J]. Tuberc Respir Dis (Seoul), 2022, 85(3): 249-255. DOI: 10.4046/trd.2022.0004.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (156) PDF downloads(71) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return